Market Closed -
Warsaw S.E.
11:55:44 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
33.6
PLN
|
-1.75%
|
|
+3.38%
|
-12.27%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
192.9
|
353.9
|
412.2
|
548
|
523.7
|
828.8
|
Enterprise Value (EV)
1 |
310.9
|
419.8
|
439.6
|
686.3
|
557.8
|
1,029
|
P/E ratio
|
7.28
x
|
8.96
x
|
5.41
x
|
5.33
x
|
4.93
x
|
55.5
x
|
Yield
|
3.55%
|
-
|
-
|
-
|
5.79%
|
-
|
Capitalization / Revenue
|
0.16
x
|
0.27
x
|
0.3
x
|
0.32
x
|
0.27
x
|
0.89
x
|
EV / Revenue
|
0.25
x
|
0.32
x
|
0.32
x
|
0.4
x
|
0.28
x
|
1.11
x
|
EV / EBITDA
|
3.47
x
|
4.48
x
|
2.98
x
|
5.65
x
|
3.05
x
|
-170
x
|
EV / FCF
|
18.8
x
|
4.55
x
|
4.3
x
|
-5.37
x
|
4.6
x
|
9.51
x
|
FCF Yield
|
5.33%
|
22%
|
23.3%
|
-18.6%
|
21.8%
|
10.5%
|
Price to Book
|
0.45
x
|
0.77
x
|
0.79
x
|
0.86
x
|
0.73
x
|
1.6
x
|
Nbr of stocks (in thousands)
|
22,834
|
22,834
|
22,834
|
22,834
|
21,639
|
21,639
|
Reference price
2 |
8.450
|
15.50
|
18.05
|
24.00
|
24.20
|
38.30
|
Announcement Date
|
5/27/19
|
5/14/20
|
4/22/21
|
5/2/22
|
4/21/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,228
|
1,326
|
1,385
|
1,728
|
1,963
|
930.2
|
EBITDA
1 |
89.72
|
93.72
|
147.4
|
121.4
|
182.6
|
-6.059
|
EBIT
1 |
64.85
|
70.01
|
123
|
93.05
|
153.4
|
-7.218
|
Operating Margin
|
5.28%
|
5.28%
|
8.89%
|
5.38%
|
7.81%
|
-0.78%
|
Earnings before Tax (EBT)
1 |
37.26
|
56.91
|
95.29
|
88.42
|
134.2
|
13.6
|
Net income
1 |
26.6
|
39.5
|
76.24
|
102.7
|
112.1
|
15.8
|
Net margin
|
2.17%
|
2.98%
|
5.51%
|
5.94%
|
5.71%
|
1.7%
|
EPS
2 |
1.160
|
1.730
|
3.339
|
4.500
|
4.910
|
0.6900
|
Free Cash Flow
1 |
16.57
|
92.22
|
102.3
|
-127.8
|
121.4
|
108.2
|
FCF margin
|
1.35%
|
6.95%
|
7.39%
|
-7.4%
|
6.18%
|
11.64%
|
FCF Conversion (EBITDA)
|
18.47%
|
98.4%
|
69.39%
|
-
|
66.47%
|
-
|
FCF Conversion (Net income)
|
62.29%
|
233.47%
|
134.19%
|
-
|
108.27%
|
685.2%
|
Dividend per Share
2 |
0.3000
|
-
|
-
|
-
|
1.400
|
-
|
Announcement Date
|
5/27/19
|
5/14/20
|
4/22/21
|
5/2/22
|
4/21/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
118
|
65.9
|
27.4
|
138
|
34.2
|
200
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.315
x
|
0.7028
x
|
0.186
x
|
1.139
x
|
0.1872
x
|
-33.05
x
|
Free Cash Flow
1 |
16.6
|
92.2
|
102
|
-128
|
121
|
108
|
ROE (net income / shareholders' equity)
|
6.38%
|
8.97%
|
15.5%
|
18.1%
|
17.1%
|
3%
|
ROA (Net income/ Total Assets)
|
5.01%
|
5.32%
|
8.67%
|
5.69%
|
8.41%
|
-0.49%
|
Assets
1 |
530.8
|
742
|
879.7
|
1,806
|
1,333
|
-3,236
|
Book Value Per Share
2 |
18.60
|
20.10
|
22.90
|
27.80
|
33.00
|
24.00
|
Cash Flow per Share
2 |
1.990
|
3.750
|
2.410
|
1.800
|
4.640
|
0.0200
|
Capex
1 |
26.6
|
26.3
|
33.2
|
32.6
|
37.2
|
31
|
Capex / Sales
|
2.17%
|
1.98%
|
2.4%
|
1.88%
|
1.89%
|
3.34%
|
Announcement Date
|
5/27/19
|
5/14/20
|
4/22/21
|
5/2/22
|
4/21/23
|
4/17/24
|
|
1st Jan change
|
Capi.
|
---|
| -12.27% | 180M | | +13.43% | 64.66B | | -3.80% | 46.08B | | +13.26% | 39.72B | | +19.46% | 25.82B | | +8.22% | 18.8B | | -0.60% | 17.14B | | -21.03% | 15.86B | | +1.06% | 15.05B | | -17.64% | 14.14B |
Other Specialty Chemicals
|